1. Bieber, T. (2008) Atopic dermatitis. The New England journal of medicine 358, 1483-1494
2. Ring, J., Alomar, A., Bieber, T., Deleuran, M., Fink-Wagner, A., Gelmetti, C., Gieler, U., Lipozencic, J., Luger, T., Oranje, A. P., Schafer, T., Schwennesen, T., Seidenari, S., Simon, D., Stander, S., Stingl, G., Szalai, S., Szepietowski, J. C., Taieb, A., Werfel, T., Wollenberg, A., and Darsow, U. (2012) Guidelines for treatment of atopic eczema (atopic dermatitis) part I. Journal of the European Academy of Dermatology and Venereology : JEADV 26, 1045-1060
3. Boguniewicz, M., Alexis, A. F., Beck, L. A., Block, J., Eichenfield, L. F., Fonacier, L., Guttman-Yassky, E., Paller, A. S., Pariser, D., Silverberg, J. I., and Lebwohl, M. (2017) Expert Perspectives on Management of Moderate-to-Severe Atopic Dermatitis: A Multidisciplinary Consensus Addressing Current and Emerging Therapies. The journal of allergy and clinical immunology. In practice 5, 1519-1531
4. Ungar, B., Garcet, S., Gonzalez, J., Dhingra, N., Correa da Rosa, J., Shemer, A., Krueger, J. G., Suarez-Farinas, M., and Guttman-Yassky, E. (2017) An Integrated Model of Atopic Dermatitis Biomarkers Highlights the Systemic Nature of the Disease. The Journal of investigative dermatology 137, 603-613
5. Werfel, T., Allam, J. P., Biedermann, T., Eyerich, K., Gilles, S., Guttman-Yassky, E., Hoetzenecker, W., Knol, E., Simon, H. U., Wollenberg, A., Bieber, T., Lauener, R., Schmid-Grendelmeier, P., Traidl-Hoffmann, C., and Akdis, C. A. (2016) Cellular and molecular immunologic mechanisms in patients with atopic dermatitis. The Journal of allergy and clinical immunology 138, 336-349
6. Malhotra, N., Yoon, J., Leyva-Castillo, J. M., Galand, C., Archer, N., Miller, L. S., and Geha, R. S. (2016) IL-22 derived from gammadelta T cells restricts Staphylococcus aureus infection of mechanically injured skin. The Journal of allergy and clinical immunology 138, 1098-1107 e1093
7. Sugaya, M. (2020) The Role of Th17-Related Cytokines in Atopic Dermatitis. International journal of molecular sciences 21
8. Megna, M., Napolitano, M., Patruno, C., Villani, A., Balato, A., Monfrecola, G., Ayala, F., and Balato, N. (2017) Systemic Treatment of Adult Atopic Dermatitis: A Review. Dermatology and therapy 7, 1-23
9. Ring, J., Alomar, A., Bieber, T., Deleuran, M., Fink-Wagner, A., Gelmetti, C., Gieler, U., Lipozencic, J., Luger, T., Oranje, A. P., Schafer, T., Schwennesen, T., Seidenari, S., Simon, D., Stander, S., Stingl, G., Szalai, S., Szepietowski, J. C., Taieb, A., Werfel, T., Wollenberg, A., and Darsow, U. (2012) Guidelines for treatment of atopic eczema (atopic dermatitis) Part II. Journal of the European Academy of Dermatology and Venereology : JEADV 26, 1176-1193
10. Jain, J., Loh, C., and Rao, A. (1995) Transcriptional regulation of the IL-2 gene. Current opinion in immunology 7, 333-342
11. McCaffrey, P. G., Goldfeld, A. E., and Rao, A. (1994) The role of NFATp in cyclosporin A-sensitive tumor necrosis factor-alpha gene transcription. The Journal of biological chemistry 269, 30445-30450
12. Shaw, J. P., Utz, P. J., Durand, D. B., Toole, J. J., Emmel, E. A., and Crabtree, G. R. (1988) Identification of a putative regulator of early T cell activation genes. Science 241, 202-205
13. Sommerer, C., Meuer, S., Zeier, M., and Giese, T. (2012) Calcineurin inhibitors and NFAT-regulated gene expression. Clinica chimica acta; international journal of clinical chemistry 413, 1379-1386
14. Srikanth, S., and Gwack, Y. (2013) Orai1-NFAT signalling pathway triggered by T cell receptor stimulation. Molecules and cells 35, 182-194
15. Crabtree, G. R., and Olson, E. N. (2002) NFAT signaling: choreographing the social lives of cells. Cell 109 Suppl, S67-79
16. Di Capite, J., and Parekh, A. B. (2009) CRAC channels and Ca2+ signaling in mast cells. Immunological reviews 231, 45-58
17. Oh-hora, M., and Rao, A. (2008) Calcium signaling in lymphocytes. Current opinion in immunology 20, 250-258
18. Prakriya, M., Feske, S., Gwack, Y., Srikanth, S., Rao, A., and Hogan, P. G. (2006) Orai1 is an essential pore subunit of the CRAC channel. Nature 443, 230-233
19. Feske, S., Gwack, Y., Prakriya, M., Srikanth, S., Puppel, S. H., Tanasa, B., Hogan, P. G., Lewis, R. S., Daly, M., and Rao, A. (2006) A mutation in Orai1 causes immune deficiency by abrogating CRAC channel function. Nature 441, 179-185
20. Feske, S. (2009) ORAI1 and STIM1 deficiency in human and mice: roles of store- operated Ca2+ entry in the immune system and beyond. Immunological reviews 231, 189-209
21. Vig, M., DeHaven, W. I., Bird, G. S., Billingsley, J. M., Wang, H., Rao, P. E., Hutchings, A. B., Jouvin, M. H., Putney, J. W., and Kinet, J. P. (2008) Defective mast cell effector functions in mice lacking the CRACM1 pore subunit of store- operated calcium release-activated calcium channels. Nature immunology 9, 89-96
22. Hoth, M., and Niemeyer, B. A. (2013) The neglected CRAC proteins: Orai2, Orai3, and STIM2. Current topics in membranes 71, 237-271
23. Prakriya, M., and Lewis, R. S. (2015) Store-Operated Calcium Channels. Physiological reviews 95, 1383-1436
24. Ong, H. L., and Ambudkar, I. S. (2020) No social distancing between ORAI channels. Cell calcium 91, 102262
25. Lacruz, R. S., and Feske, S. (2015) Diseases caused by mutations in ORAI1 and STIM1. Annals of the New York Academy of Sciences 1356, 45-79
26. Tian, C., Du, L., Zhou, Y., and Li, M. (2016) Store-operated CRAC channel inhibitors: opportunities and challenges. Future medicinal chemistry 8, 817-832
27. Feske, S. (2007) Calcium signalling in lymphocyte activation and disease. Nature reviews. Immunology 7, 690-702
28. Liou, J., Kim, M. L., Heo, W. D., Jones, J. T., Myers, J. W., Ferrell, J. E., Jr., and Meyer, T. (2005) STIM is a Ca2+ sensor essential for Ca2+-store-depletion-triggered Ca2+ influx. Current biology : CB 15, 1235-1241
29. Stauderman, K. A. (2018) CRAC channels as targets for drug discovery and development. Cell calcium 74, 147-159
30. Shuttleworth, T. J. (2012) Orai3--the 'exceptional' Orai? The Journal of physiology 590, 241-257
31. Takatsuka, S., Sekiguchi, A., Tokunaga, M., Fujimoto, A., and Chiba, J. (2011) Generation of a panel of monoclonal antibodies against atypical chemokine receptor CCX-CKR by DNA immunization. Journal of pharmacological and toxicological methods 63, 250-257
32. Aki, A., Tanaka, K., Nagaoka, N., Kimura, T., Baba, D., Onodera, Y., Wada, T., Maeda, H., Nakanishi, T., Agatsuma, T., and Komai, T. (2020) Anti-ORAI1 antibody DS-2741a, a specific CRAC channel blocker, shows ideal therapeutic profiles for allergic disease via suppression of aberrant T-cell and mast cell activation. FASEB bioAdvances 2, 478-488
33. (2018) In Calcium Entry Channels in Non-Excitable Cells (Kozak, J. A., and Putney, J. W., Jr., eds), Boca Raton (FL)
34. Luckheeram, R. V., Zhou, R., Verma, A. D., and Xia, B. (2012) CD4(+)T cells: differentiation and functions. Clinical & developmental immunology 2012, 925135
35. Hirahara, K., and Nakayama, T. (2016) CD4+ T-cell subsets in inflammatory diseases: beyond the Th1/Th2 paradigm. International immunology 28, 163-171
36. Cevikbas, F., Wang, X., Akiyama, T., Kempkes, C., Savinko, T., Antal, A., Kukova, G., Buhl, T., Ikoma, A., Buddenkotte, J., Soumelis, V., Feld, M., Alenius, H., Dillon, S. R., Carstens, E., Homey, B., Basbaum, A., and Steinhoff, M. (2014) A sensory neuron-expressed IL-31 receptor mediates T helper cell-dependent itch: Involvement of TRPV1 and TRPA1. The Journal of allergy and clinical immunology 133, 448-460
37. Ruzicka, T., Hanifin, J. M., Furue, M., Pulka, G., Mlynarczyk, I., Wollenberg, A., Galus, R., Etoh, T., Mihara, R., Yoshida, H., Stewart, J., and Kabashima, K. (2017) Anti-Interleukin-31 Receptor A Antibody for Atopic Dermatitis. The New England journal of medicine 376, 826-835
38. Chang, W. C., Lee, C. H., Hirota, T., Wang, L. F., Doi, S., Miyatake, A., Enomoto, T., Tomita, K., Sakashita, M., Yamada, T., Fujieda, S., Ebe, K., Saeki, H., Takeuchi, S., Furue, M., Chen, W. C., Chiu, Y. C., Chang, W. P., Hong, C. H., Hsi, E., Juo, S. H., Yu, H. S., Nakamura, Y., and Tamari, M. (2012) ORAI1 genetic polymorphisms associated with the susceptibility of atopic dermatitis in Japanese and Taiwanese populations. PloS one 7, e29387
39. Yeh, Y. C., Lin, Y. P., Kramer, H., and Parekh, A. B. (2020) Single-nucleotide polymorphisms in Orai1 associated with atopic dermatitis inhibit protein turnover, decrease calcium entry and disrupt calcium-dependent gene expression. Human molecular genetics 29, 1808-1823
40. Brunner, P. M., Guttman-Yassky, E., and Leung, D. Y. (2017) The immunology of atopic dermatitis and its reversibility with broad-spectrum and targeted therapies. The Journal of allergy and clinical immunology 139, S65-S76
41. Zeiser, R., Nguyen, V. H., Beilhack, A., Buess, M., Schulz, S., Baker, J., Contag, C. H., and Negrin, R. S. (2006) Inhibition of CD4+CD25+ regulatory T-cell function by calcineurin-dependent interleukin-2 production. Blood 108, 390-399
42. Akimova, T., Kamath, B. M., Goebel, J. W., Meyers, K. E., Rand, E. B., Hawkins, A., Levine, M. H., Bucuvalas, J. C., and Hancock, W. W. (2012) Differing effects of rapamycin or calcineurin inhibitor on T-regulatory cells in pediatric liver and kidney transplant recipients. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 12, 3449-3461
43. Wu, Y., Borde, M., Heissmeyer, V., Feuerer, M., Lapan, A. D., Stroud, J. C., Bates, D. L., Guo, L., Han, A., Ziegler, S. F., Mathis, D., Benoist, C., Chen, L., and Rao, A. (2006) FOXP3 controls regulatory T cell function through cooperation with NFAT. Cell 126, 375-387
44. Li, X., Liang, Y., LeBlanc, M., Benner, C., and Zheng, Y. (2014) Function of a Foxp3 cis-element in protecting regulatory T cell identity. Cell 158, 734-748
45. Kaufmann, U., Shaw, P. J., Kozhaya, L., Subramanian, R., Gaida, K., Unutmaz, D., McBride, H. J., and Feske, S. (2016) Selective ORAI1 Inhibition Ameliorates Autoimmune Central Nervous System Inflammation by Suppressing Effector but Not Regulatory T Cell Function. J Immunol 196, 573-585
46. McCarl, C. A., Khalil, S., Ma, J., Oh-hora, M., Yamashita, M., Roether, J., Kawasaki, T., Jairaman, A., Sasaki, Y., Prakriya, M., and Feske, S. (2010) Store-operated Ca2+ entry through ORAI1 is critical for T cell-mediated autoimmunity and allograft rejection. J Immunol 185, 5845-5858
47. Vaeth, M., Yang, J., Yamashita, M., Zee, I., Eckstein, M., Knosp, C., Kaufmann, U., Karoly Jani, P., Lacruz, R. S., Flockerzi, V., Kacskovics, I., Prakriya, M., and Feske, S. (2017) ORAI2 modulates store-operated calcium entry and T cell-mediated immunity. Nature communications 8, 14714
48. Kawakami, T., Ando, T., Kimura, M., Wilson, B. S., and Kawakami, Y. (2009) Mast cells in atopic dermatitis. Current opinion in immunology 21, 666-678
49. Soter, N. A. (1989) Morphology of atopic eczema. Allergy 44 Suppl 9, 16-19
50. Ui, H., Andoh, T., Lee, J. B., Nojima, H., and Kuraishi, Y. (2006) Potent pruritogenic action of tryptase mediated by PAR-2 receptor and its involvement in anti-pruritic effect of nafamostat mesilate in mice. European journal of pharmacology 530, 172- 178
51. Zhao, L., Jin, H., She, R., Hu, Y., Xiao, C., Yu, Y., Wang, J., Sun, F., Ng, T., Chu, S., and Wang, B. (2006) A rodent model for allergic dermatitis induced by flea antigens. Veterinary immunology and immunopathology 114, 285-296
52. Knol, E. F. (2006) Requirements for effective IgE cross-linking on mast cells and basophils. Molecular nutrition & food research 50, 620-624
53. Kuehn, H. S., Radinger, M., and Gilfillan, A. M. (2010) Measuring mast cell mediator release. Current protocols in immunology Chapter 7, Unit7 38
54. Foreman, J. C., and Mongar, J. L. (1973) The interaction of calcium and strontium with phosphatidyl serine in the anaphylactic secretion of histamine. The Journal of physiology 230, 493-507
55. Oka, T., Rios, E. J., Tsai, M., Kalesnikoff, J., and Galli, S. J. (2013) Rapid desensitization induces internalization of antigen-specific IgE on mouse mast cells. The Journal of allergy and clinical immunology 132, 922-932 e921-916
56. Ovary, Z. (1958) Passive cutaneous anaphylaxis in the mouse. J Immunol 81, 355-357
57. Kawakami, Y., Yumoto, K., and Kawakami, T. (2007) An improved mouse model of atopic dermatitis and suppression of skin lesions by an inhibitor of Tec family kinases. Allergology international : official journal of the Japanese Society of Allergology 56, 403-409
58. Oshio, T., Sasaki, Y., Funakoshi-Tago, M., Aizu-Yokota, E., Sonoda, Y., Matsuoka, H., and Kasahara, T. (2009) Dermatophagoides farinae extract induces severe atopic dermatitis in NC/Nga mice, which is effectively suppressed by the administration of tacrolimus ointment. International immunopharmacology 9, 403- 411
59. Matsuoka, H., Maki, N., Yoshida, S., Arai, M., Wang, J., Oikawa, Y., Ikeda, T., Hirota, N., Nakagawa, H., and Ishii, A. (2003) A mouse model of the atopic eczema/dermatitis syndrome by repeated application of a crude extract of house- dust mite Dermatophagoides farinae. Allergy 58, 139-145
60. Thomsen, S. F. (2014) Atopic dermatitis: natural history, diagnosis, and treatment. ISRN allergy 2014, 354250
61. Harris, H. (1989) The biology of tumour suppression. Ciba Foundation symposium142, 199-208; discussion 208-113
62. Savinko, T., Lauerma, A., Lehtimaki, S., Gombert, M., Majuri, M. L., Fyhrquist- Vanni, N., Dieu-Nosjean, M. C., Kemeny, L., Wolff, H., Homey, B., and Alenius, H. (2005) Topical superantigen exposure induces epidermal accumulation of CD8+ T cells, a mixed Th1/Th2-type dermatitis and vigorous production of IgE antibodies in the murine model of atopic dermatitis. J Immunol 175, 8320-8326
63. Kim, M. C., Lee, C. H., and Yook, T. H. (2013) Effects of anti-inflammatory and Rehmanniae radix pharmacopuncture on atopic dermatitis in NC/Nga mice. Journal of acupuncture and meridian studies 6, 98-109
64. Kupin, W. L., Venkat, K. K., Norris, C., Florence-Green, D., Dienst, S., Oh, H. K., Feldkamp, C., and Levin, N. W. (1987) Effective long-term immunosuppression maintained by low cyclosporine levels in primary cadaveric renal transplant recipients. Transplantation 43, 214-218
65. Vanhove, T., Remijsen, Q., Kuypers, D., and Gillard, P. (2017) Drug-drug interactions between immunosuppressants and antidiabetic drugs in the treatment of post-transplant diabetes mellitus. Transplant Rev (Orlando) 31, 69-77
66. Vercauteren, S. B., Bosmans, J. L., Elseviers, M. M., Verpooten, G. A., and De Broe, M. E. (1998) A meta-analysis and morphological review of cyclosporine-induced nephrotoxicity in auto-immune diseases. Kidney international 54, 536-545
67. Beck, L. A., Thaci, D., Hamilton, J. D., Graham, N. M., Bieber, T., Rocklin, R., Ming, J. E., Ren, H., Kao, R., Simpson, E., Ardeleanu, M., Weinstein, S. P., Pirozzi, G., Guttman-Yassky, E., Suarez-Farinas, M., Hager, M. D., Stahl, N., Yancopoulos, G. D., and Radin, A. R. (2014) Dupilumab treatment in adults with moderate-to-severe atopic dermatitis. The New England journal of medicine 371, 130-139
68. Simpson, E. L., Bieber, T., Guttman-Yassky, E., Beck, L. A., Blauvelt, A., Cork, M. J., Silverberg, J. I., Deleuran, M., Kataoka, Y., Lacour, J. P., Kingo, K., Worm, M., Poulin, Y., Wollenberg, A., Soo, Y., Graham, N. M., Pirozzi, G., Akinlade, B., Staudinger, H., Mastey, V., Eckert, L., Gadkari, A., Stahl, N., Yancopoulos, G. D., and Ardeleanu, M. (2016) Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis. The New England journal of medicine 375, 2335-2348
69. Gittler, J. K., Shemer, A., Suarez-Farinas, M., Fuentes-Duculan, J., Gulewicz, K. J., Wang, C. Q., Mitsui, H., Cardinale, I., de Guzman Strong, C., Krueger, J. G., and Guttman-Yassky, E. (2012) Progressive activation of T(H)2/T(H)22 cytokines and selective epidermal proteins characterizes acute and chronic atopic dermatitis. The Journal of allergy and clinical immunology 130, 1344-1354
70. Guttman-Yassky, E., Krueger, J. G., and Lebwohl, M. G. (2018) Systemic immune mechanisms in atopic dermatitis and psoriasis with implications for treatment. Experimental dermatology 27, 409-417
71. Eyerich, K., and Novak, N. (2013) Immunology of atopic eczema: overcoming the Th1/Th2 paradigm. Allergy 68, 974-982
72. Napolitano, M., Caiazzo, G., Fabbrocini, G., Balato, A., Di Caprio, R., Scala, E., Scalvenzi, M., and Patruno, C. (2020) Increased expression of IL-23A in lesional skin of atopic dermatitis patients with psoriasiform reaction during dupilumab treatment. The British journal of dermatology
73. Jaulent, L., Staumont-Salle, D., Tauber, M., Paul, C., Aubert, H., Marchetti, A., Sassolas, B., Valois, A., Nicolas, J. F., and Nosbaum, A. (2020) De novo psoriasis in atopic dermatitis patients treated with dupilumab: a retrospective cohort. Journal of the European Academy of Dermatology and Venereology : JEADV
74. Verdonk, R. C., Haagsma, E. B., Jonker, M. R., Bok, L. I., Zandvoort, J. H., Kleibeuker, J. H., Faber, K. N., and Dijkstra, G. (2007) Effects of different immunosuppressive regimens on regulatory T-cells in noninflamed colon of liver transplant recipients. Inflammatory bowel diseases 13, 703-709
75. Satake, A., Schmidt, A. M., Nomura, S., and Kambayashi, T. (2014) Inhibition of calcineurin abrogates while inhibition of mTOR promotes regulatory T cell expansion and graft-versus-host disease protection by IL-2 in allogeneic bone marrow transplantation. PloS one 9, e92888
76. Oetjen, L. K., Mack, M. R., Feng, J., Whelan, T. M., Niu, H., Guo, C. J., Chen, S., Trier, A. M., Xu, A. Z., Tripathi, S. V., Luo, J., Gao, X., Yang, L., Hamilton, S. L., Wang, P. L., Brestoff, J. R., Council, M. L., Brasington, R., Schaffer, A., Brombacher, F., Hsieh, C. S., Gereau, R. W. t., Miller, M. J., Chen, Z. F., Hu, H., Davidson, S., Liu, Q., and Kim, B. S. (2017) Sensory Neurons Co-opt Classical Immune Signaling Pathways to Mediate Chronic Itch. Cell 171, 217-228 e213
77. Silverberg, J. I., Yosipovitch, G., Simpson, E. L., Kim, B. S., Wu, J. J., Eckert, L., Guillemin, I., Chen, Z., Ardeleanu, M., Bansal, A., Kaur, M., Rossi, A. B., Graham, N. M. H., Patel, N., and Gadkari, A. (2020) Dupilumab treatment results in early and sustained improvements in itch in adolescents and adults with moderate to severe atopic dermatitis: Analysis of the randomized phase 3 studies SOLO 1 and SOLO 2, AD ADOL, and CHRONOS. Journal of the American Academy of Dermatology 82, 1328-1336
78. Kabashima, K., Matsumura, T., Komazaki, H., and Kawashima, M. (2020) Trial of Nemolizumab and Topical Agents for Atopic Dermatitis with Pruritus. The New England journal of medicine 383, 141-150
79. Wilson, S. R., The, L., Batia, L. M., Beattie, K., Katibah, G. E., McClain, S. P., Pellegrino, M., Estandian, D. M., and Bautista, D. M. (2013) The epithelial cell- derived atopic dermatitis cytokine TSLP activates neurons to induce itch. Cell 155, 285-295
80. Shimada, S. G., Shimada, K. A., and Collins, J. G. (2006) Scratching behavior in mice induced by the proteinase-activated receptor-2 agonist, SLIGRL-NH2. European journal of pharmacology 530, 281-283
論文の公開元へ
